What Is a Nephroureterectomy? Procedure and Recovery

A nephroureterectomy is a surgical procedure that removes an entire kidney along with its ureter (the tube connecting the kidney to the bladder) and a small cuff of bladder tissue where the ureter connects. It is the standard treatment for upper tract urothelial carcinoma, a cancer that arises in the lining of the kidney’s drainage system or the ureter. The operation can be performed through a traditional open incision or with minimally invasive techniques, and recovery typically involves a hospital stay of roughly one to two weeks followed by several weeks of gradual return to normal activity.

Why the Procedure Is Performed

The urinary tract is lined by a type of tissue called urothelium, and cancers arising from this lining can develop not only in the bladder but also higher up in the system, in the renal pelvis (inside the kidney) or along the ureter. These upper tract urothelial carcinomas account for a small fraction of all urothelial cancers, but they tend to be aggressive. Because the entire length of ureter and the kidney’s collecting system share the same lining, cancer cells can seed along the tract. Removing the kidney, the full ureter, and a ring of bladder tissue around the ureteral opening addresses that risk in one operation.

Radical nephroureterectomy remains the gold standard for high-grade or clinically invasive upper tract urothelial carcinoma.¹ For tumors that are small, low-grade, and confined to the surface, kidney-sparing approaches are sometimes an option, but for anything more advanced, the complete removal is considered the most reliable way to control the disease.

Open, Laparoscopic, and Robotic Approaches

Surgeons perform nephroureterectomy using three main techniques. The traditional open approach involves one or two incisions in the abdomen and flank. Laparoscopic surgery uses several small incisions and a camera, with the surgeon manipulating instruments from outside the body. Robotic surgery is similar to laparoscopic but adds a robotic platform that gives the surgeon enhanced precision and a three-dimensional view.

A large comparative study found that both laparoscopic and robotic approaches resulted in significantly less blood loss and shorter hospital stays than the open technique, though they took longer in the operating room.² A systematic review of observational studies quantified the difference in blood loss: open procedures ranged from roughly 300 to 700 mL, laparoscopic from about 130 to 480 mL, and robotic from 50 to 250 mL.³ Patients who had minimally invasive surgery also needed less pain medication afterward.²

Complication rates during and shortly after surgery were similar across all three approaches. Intraoperative complications occurred in about 5 to 8 percent of patients regardless of technique, and early postoperative complications in roughly 14 to 15 percent.² Long-term cancer control also appears equivalent across methods once you account for patient and tumor characteristics. Robotic cases initially looked better in survival analyses, but that advantage disappeared after adjusting for other factors, suggesting the patients selected for robotic surgery were healthier or had earlier-stage disease to begin with.²

The Bladder Cuff and Why It Matters

One detail that makes nephroureterectomy distinctive compared to a simple kidney removal is the bladder cuff excision. The surgeon removes a small disc of bladder wall surrounding the spot where the ureter enters the bladder. Skipping this step would leave behind urothelial tissue that is at high risk for developing cancer, since the same cellular changes that caused the upper tract tumor can affect the bladder lining nearby.

Managing the distal ureter and bladder cuff is technically one of the most challenging parts of the operation, and surgeons have developed various techniques for it. Some do it through a separate small incision near the pelvis, some handle it endoscopically, and newer robotic methods allow the surgeon to visualize the ureteral opening directly and excise the cuff without a second incision.⁴ How the bladder cuff is managed can influence both complications and the risk of cancer recurring in the bladder, which is why this seemingly small technical detail gets a lot of attention in the surgical literature.

Chemotherapy at the Time of Surgery

A somewhat counterintuitive step in modern nephroureterectomy is that many surgeons instill a dose of chemotherapy directly into the bladder during or immediately after the operation. The reason has to do with the high rate of bladder cancer recurrence after this surgery. Cancer cells shed from the upper tract tumor can implant in the bladder lining, and the surgical manipulation itself can dislodge cells.

A Cochrane review found that a single dose of intravesical chemotherapy roughly halved the risk of later bladder cancer recurrence, translating to about 127 fewer recurrences per 1,000 patients over the following year.⁵ The evidence quality is limited, but the benefit-to-risk ratio is favorable because it is a single instillation with few side effects rather than a full course of systemic chemotherapy. Mitomycin C is the most commonly used agent for this purpose.

Separate from the intravesical dose, some patients with high-risk disease receive systemic chemotherapy before surgery. A meta-analysis of available studies examined whether giving chemotherapy before nephroureterectomy improves outcomes, and while early phase II trials have shown encouraging response rates, the evidence is not yet strong enough for routine recommendation in guidelines.⁶ This is an active area of research, particularly because once a kidney is removed, the remaining kidney may not tolerate the most effective chemotherapy drugs as well.

What Recovery Looks Like in the Hospital

Hospital stays after nephroureterectomy vary depending on the surgical approach, the patient’s overall health, and whether the hospital uses an accelerated recovery program. A study comparing outcomes before and after implementing an enhanced recovery protocol found that structured protocols significantly shortened time in the hospital. Patients on the enhanced protocol had a total stay of about 15 days compared to 21 days without it, and the portion of the stay after surgery dropped from about 11 days to 8 days.⁷ These numbers come from a single institution and reflect practices that include preoperative admission time, so your own stay could be shorter or longer depending on the center.

Enhanced recovery protocols typically involve getting patients moving within hours of surgery, transitioning from IV fluids to oral intake as quickly as the gut tolerates, and minimizing the use of opioid pain medications. These programs have become widespread in major urologic surgery and consistently reduce both hospital time and costs.

Because the bladder is opened during cuff excision, a urinary catheter stays in place while that small wound heals. In published series, catheter removal typically happened around six to seven days after surgery, with a range of about three to fifteen days depending on how well the bladder sealed.^{8 9} A leak test using imaging is sometimes performed before removal to confirm the bladder closure is watertight. Most people find the catheter uncomfortable but manageable, and once it is removed, normal urination resumes fairly quickly from the remaining kidney.

Possible Complications

Like any major abdominal surgery, nephroureterectomy carries risks. The most common early complications include bowel sluggishness (paralytic ileus), wound issues, urinary tract infections, and bleeding that occasionally requires transfusion. A study comparing different minimally invasive techniques found that hand-assisted laparoscopic approaches carried a higher risk of major complications and paralytic ileus than purely laparoscopic or robotic methods.¹⁰ That same study noted a significantly higher rate of postoperative end-stage kidney disease with the hand-assisted approach, though this likely reflects the patient population selected for that technique rather than the technique itself.

Overall, the complication profile is broadly similar to that of other major kidney surgeries. Most complications are managed with conservative measures, and serious events requiring reoperation are uncommon.

What Happens to Your Kidney Function

Losing an entire kidney inevitably affects your filtration capacity. A large multicenter study tracking kidney function after nephroureterectomy found that about 70 percent of patients had reduced kidney function (below the threshold considered normal) at both 6 and 12 months after surgery.¹¹ The remaining kidney compensates by increasing its workload, and for most people, that single kidney is enough to maintain health. But the patients most at risk for significant decline are those who already had reduced function before the operation, are older, or experience an acute kidney stress in the days right after surgery.¹¹

This matters beyond the kidneys themselves. Reduced kidney function can limit your eligibility for certain chemotherapy drugs after surgery, including the platinum-based regimens most effective against urothelial cancer. It is one reason why giving chemotherapy before the operation, while both kidneys are still present, is increasingly discussed for patients with high-risk disease.

Living with a Solitary Kidney

After nephroureterectomy, you are functionally a person with a single kidney. Most people live entirely normal lives with one kidney, but there are practical adjustments worth knowing about. Expert recommendations for people with an acquired solitary kidney include keeping daily protein intake moderate rather than very high, limiting sodium, maintaining a healthy weight, eating adequate fiber from plant-based foods, and carefully managing any conditions that threaten kidney health, such as high blood pressure or diabetes.¹²

You do not need to avoid exercise or physical activity. The remaining kidney sits well protected behind the rib cage and back muscles. Contact sports may require some individual discussion with your doctor, but daily activity, cardiovascular exercise, and strength training are all encouraged. Staying hydrated is sensible but does not require any unusual water intake beyond what you would do normally. The key long-term goal is keeping blood pressure in a healthy range, since high blood pressure accelerates damage to a solitary kidney faster than it would with two.

Follow-Up Surveillance After Surgery

Cancer surveillance after nephroureterectomy is intensive and lasts for years, because upper tract urothelial carcinoma has a meaningful risk of coming back in two distinct places: the bladder and elsewhere in the body.

Bladder recurrence is the more common of the two. A large multicenter study found that about 31 percent of patients developed a new bladder tumor after nephroureterectomy, with most of these appearing within the first two years.¹³ Factors that increase the risk include having had a previous bladder cancer, a tumor located in the ureter rather than the kidney, and more advanced stage disease. Surveillance for bladder recurrence involves regular cystoscopy, where a thin camera is passed through the urethra to inspect the bladder lining.

Non-bladder recurrences, meaning cancer returning at distant sites or in the remaining urinary tract, are tracked with imaging. A large surveillance study found that the risk of non-bladder recurrence at two years ranged from about 42 to 47 percent for different patient groups, dropping to about 23 percent at four years as the remaining at-risk patients thinned out.¹⁴ The same study offered guidance on how long to continue monitoring: younger patients without a history of bladder cancer should keep up with both cystoscopies and imaging beyond 10 years, while very elderly patients might reasonably stop at some point because other causes of death outweigh the remaining cancer risk.¹⁴

The follow-up schedule typically starts with visits every three to four months in the first two years, then gradually spaces out. Each visit usually includes blood work, imaging of the chest and abdomen, and cystoscopy. It is a significant time commitment, but catching a recurrence early, especially in the bladder, offers the best chance of successful treatment.

When the Whole Kidney Does Not Need to Come Out

Not everyone with an upper tract tumor needs a full nephroureterectomy. For small, low-grade tumors that sit on the surface of the urothelium without invading deeper layers, kidney-sparing approaches can provide similar cancer outcomes while preserving the organ. These include ureteroscopic ablation, where a flexible scope is threaded up through the bladder to laser or burn the tumor, and segmental ureterectomy, where only the affected portion of the ureter is removed and the ends are reconnected.

A systematic review by the European Association of Urology found that patients with low-grade, noninvasive tumors had similar cancer-specific survival after kidney-sparing surgery compared to radical nephroureterectomy, though they faced a higher rate of local recurrence requiring additional procedures.¹⁵ Guidelines now recommend kidney-sparing surgery as the preferred approach for favorable low-risk disease, and it is particularly valuable for patients who already have compromised kidney function or only one functioning kidney.¹⁶

The tradeoff is clear: keeping the kidney means accepting a higher chance of needing repeat procedures to treat local recurrences, while removing it provides a more definitive surgical cure but at the cost of kidney function. The choice depends on tumor characteristics, the health of the opposite kidney, and the patient’s overall fitness and preferences.

Preparing for Surgery and Preoperative Fitness

Patients facing nephroureterectomy tend to be older and often come to surgery in less-than-ideal physical condition. A study assessing preoperative fitness in cancer patients scheduled for kidney removal or nephroureterectomy found that about two-thirds of upper tract carcinoma patients were at nutritional risk before surgery, roughly one in five met criteria for frailty, and over half had anemia. More than a third showed functional impairment on a standard walking test.¹⁷

These numbers highlight why prehabilitation, a structured program of exercise, nutrition, and psychological support before surgery, is gaining attention. Even a few weeks of targeted walking, resistance exercises, and dietary optimization can improve a patient’s ability to tolerate surgery and recover faster. Correcting anemia and nutritional deficits beforehand reduces the chance of needing blood transfusions and shortens the time to regain independence.

If you or a family member is facing this surgery, it is worth asking your surgical team about prehabilitation resources. Not every hospital offers a formal program, but even informal guidance on increasing daily walking, eating more protein, and doing simple strength exercises in the weeks before surgery can make a measurable difference. The operation itself is only part of the process; how you arrive at the operating table shapes how quickly you leave it.